相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapies for diabetic dyslipidaemia
D. S. H. Bell et al.
DIABETES OBESITY & METABOLISM (2011)
Hepatic Deficiency of Low Density Lipoprotein Receptor-related Protein-1 Reduces High Density Lipoprotein Secretion and Plasma Levels in Mice
Joshua E. Basford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
Soo Jin Yang et al.
PLOS ONE (2011)
Hepatic Effects of Rosiglitazone in Rats with the Metabolic Syndrome
Zvi Ackerman et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Commentary on the study of Laatsch et al. Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance
Raul D. Santos
ATHEROSCLEROSIS (2009)
Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance
Alexander Laatsch et al.
ATHEROSCLEROSIS (2009)
Diabetic dyslipidemia: beyond LDL
M. Merkel
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2009)
The role of pioglitazone in modifying the atherogenic lipoprotein profile
M. Hanefeld
DIABETES OBESITY & METABOLISM (2009)
Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Yoshio Fujioka et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Downregulation of LPR1 at the blood-brain barrier in streptozotocin-induced diabetic mice
Hao Hong et al.
NEUROPHARMACOLOGY (2009)
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
Kaspar Berneis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
VEGF-enhanced proliferation under hypoxia by an autocrine mechanism in human vascular smooth muscle cells
Mayuko Osada-Oka et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study
C Imke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
RB Goldberg et al.
DIABETES CARE (2005)
Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes
JPH Van Wijk et al.
DIABETES CARE (2005)
Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus
H Fukushima et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
M Niemi et al.
DIABETOLOGIA (2003)
Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor γ
A Gauthier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study
EJ Schaefer et al.
DIABETES CARE (2002)
Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease
H Fukushima et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
LRP: a multifunctional scavenger and signaling receptor
J Herz et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients
A Taniguchi et al.
DIABETES CARE (2000)
Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation
S Hauser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
